Ministry of Health
The Department of Health has launched a public survey to develop the first clinical protocol and therapeutic guidelines (PCDT) for the treatment of cases of obesity and overweight. The document may receive contributions from representatives of civil society and health professionals until 11 September.
According to the ministry, the goal is to improve and qualify the care and therapeutic management of patients in basic and specialized care in the Unified Health System (SUS). The briefing notes that the approval of the protocol can contribute to the prevention and control of obesity and overweight in the country, as well as to ensuring more clinical and scientific safety and effectiveness for health professionals.
Obesity is one of the diseases that has grown the most in recent years at a global level. Data from the World Health Organization (WHO) show that the percentage of obesity and overweight has almost tripled since 1975. Worldwide there are at least 650 million people with obesity. In Brazil, one in five people is obese and according to the Vigitel Surveillance of Risk Factors and Protection for Chronic Diseases by Telephone Inquiry (Vigitel), more than half of the population of the capital is overweight.
The impact on Sus has also grown. In 2012, the public network performed just over a thousand bariatric procedures and repaired obese patients. The number of interventions rose to 8.1 thousand in 2016, according to the Ministry of Health.
The Brazilian Society of Endocrinology asked for the participation of endocrinologists in the development of the protocol. The Brazilian Nutrition Society (Abran) also expressed its support for the contribution of the nutrologists to develop the protocol, because of the concerns about the severity and the increase of the disease in the population.
"Obesity is a chronic and multifactorial disorder, ranging from environment to food, health and even genetics, because it is considered a chronic disease, alas, if you stop treating it, it comes back. pathologies, from hypertension, diabetes, high cholesterol, infarction, stroke and even cancer, "said Dimitri Homar, representative of the regional Abran region in Brasilia.
One of the demands of the specialist is the return of cheap medicines that have contributed to the treatment of obesity and that were removed from the market by the National Agency for Sanitary Surveillance (Anvisa).
The Ministry of Health explained that the poll guarantees the participation of the population from the first phase of the process of elaboration of the protocol, which must still go through a public consultation for the final deliberation.